Walid Warda

Besancon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Correction: RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.

Correction: RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.

Journal: Gene therapy

Published: December 20, 2024

RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.

RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells.

Journal: Gene therapy

Published: November 07, 2022

CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.

CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.

Journal: Current research in translational medicine

Published: July 18, 2022

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.

Journal: Journal for immunotherapy of cancer

Published: June 27, 2022

Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro.

Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro.

Journal: Immunologic research

Published: January 04, 2022

Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients.

Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients.

Journal: Journal of translational medicine

Published: April 25, 2021

EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas.

EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas.

Journal: Cancers

Published: October 28, 2020

Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Journal: Science signaling

Published: September 16, 2020

Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch.

Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch.

Journal: Cancer gene therapy

Published: September 06, 2020

Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics.

Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics.

Journal: Frontiers in oncology

Published: August 28, 2020

CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm.

CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm.

Journal: Leukemia

Published: September 03, 2019

IL-1RAP as a candidate for CAR T-cells immunotherapy

IL-1RAP as a candidate for CAR T-cells immunotherapy

Journal: Medecine sciences : M/S

Published: July 06, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026